A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries - Concepedia

Concepedia

Publication | Open Access

A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries

DOI Full Paper Access

16

Citations

28

References

2021

Year

María Victoria Humbert, Precious C. Opurum, Nathan J. Brendish, Stephen Poole, Peijun He, Ioannis Katis, Jerry Quaye, Yaw Bediako, Patrick J. Duriez, R.W. Eason,

Journal of Infection

Point-of-care TestingLateral FlowViral DiagnosticsLmi CountriesMedicineCommunity ScreeningDiagnostic TestDiagnosisCovid-19 PandemicScreeningMolecular DiagnosticsEpidemiologyCovid-19

References

	Year	Citations

Page 1

Page 1